Eric Reiman, MD

Eric Reiman, MD, Executive Director, Banner Alzheimer's Institute


The State of the Alzheimer Disease Pipeline: Eric Reiman, MD

August 06, 2021

The executive director of Banner Alzheimer’s Institute commented on ongoing research into amyloid plaque-reducing antibody therapies, the approval of aducanumab, and other initiatives with the ability to impact the treatment of Alzheimer disease.